Page last updated: 2024-09-05

aluminum hydroxide, magnesium hydroxide, drug combination and pentagastrin

aluminum hydroxide, magnesium hydroxide, drug combination has been researched along with pentagastrin in 1 studies

Compound Research Comparison

Studies
(aluminum hydroxide, magnesium hydroxide, drug combination)
Trials
(aluminum hydroxide, magnesium hydroxide, drug combination)
Recent Studies (post-2010)
(aluminum hydroxide, magnesium hydroxide, drug combination)
Studies
(pentagastrin)
Trials
(pentagastrin)
Recent Studies (post-2010) (pentagastrin)
253100173,63920751

Protein Interaction Comparison

ProteinTaxonomyaluminum hydroxide, magnesium hydroxide, drug combination (IC50)pentagastrin (IC50)
Cholecystokinin receptor type ARattus norvegicus (Norway rat)0.8875
Gastrin/cholecystokinin type B receptorHomo sapiens (human)0.001

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bridger, S; Johnston, DA; Marks, IN; Tigler-Wybrandi, NA; Young, GO; Zak, J1

Trials

1 trial(s) available for aluminum hydroxide, magnesium hydroxide, drug combination and pentagastrin

ArticleYear
Acid secretory responses and parietal cell sensitivity following duodenal ulcer healing with omeprazole, sucralfate, and Maalox.
    The American journal of medicine, 1991, Aug-08, Volume: 91, Issue:2A

    Topics: Adult; Aged; Aluminum Hydroxide; Antacids; Drug Combinations; Duodenal Ulcer; Endoscopy, Gastrointestinal; Fasting; Female; Gastric Acid; Gastric Acidity Determination; Gastrins; Humans; Magnesium Hydroxide; Male; Middle Aged; Omeprazole; Parietal Cells, Gastric; Pentagastrin; Recurrence; Sucralfate; Wound Healing

1991
chemdatabank.com